TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

J&J wins U.S. approval for TB tablet

JNJ $70.10 +$0.62

at close on MONDAY

By Anna Edney C.2012 Bloomberg News
Monday, Dec. 31, 2012, 10:30 p.m.
 

Johnson & Johnson won regulatory approval for its tuberculosis tablet Sirturo, the first drug in 40 years that provides a new way to treat the contagious lung infection.

The Food and Drug Administration cleared Sirturo to be added to therapies for use by adults whose illness is resistant to multiple medicines, the New Brunswick, N.J.- based company said Monday.

While tuberculosis was once the leading cause of death in the nation, the drug-resistant version of the illness affected about 98 people last year, according to the Centers for Disease Control and Prevention.

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Visual search  still hampered  by image issues
  2. States clear way for startups to use crowdfunding
  3. Government approves compromise on Corbett’s alternative Medicaid plan
  4. Gas drilling company withdraws application for forced pooling in Western Pennsylvania
  5. U-PARC houses companies ranging from innovative to traditional
  6. S&P 500 holds steady at 2,000 level
  7. USDA updates dairy insurance program
  8. Lower your cable bill by streaming shows
  9. Hershey unwraps new corporate logo
  10. Deported migrants find home at call centers
  11. Students walk shop class path to excellence
Subscribe today! Click here for our subscription offers.